文献速递炎症性肠病胃肠动力与功能性疾病

乳糜泻与炎症性肠病的关联:一项基于全国登记数据的队列研究

Association of Celiac Disease and Inflammatory Bowel Disease: A Nationwide Register-Based Cohort Study.
PubMed 文献 · Am J Gastroenterol · 2022-05-25

基于瑞典组织病理学与医疗登记数据,纳入1969-2016年诊断的48,551例乳糜泻患者和83,529例炎症性肠病(IBD)患者,分别与年龄性别匹配的一般人群对照比较。乳糜泻患者发生IBD的风险比为3.91(95%CI 3.56-4.31),IBD患者发生乳糜泻的风险比为5.49(95%CI 4.90-6.16),关联呈双向性且独立于时间顺序。

要点

  • 乳糜泻患者发生IBD的风险比为3.91(95%CI 3.56-4.31)。
  • IBD患者发生乳糜泻的风险比为5.49(95%CI 4.90-6.16)。
  • 20年随访中,2.5%乳糜泻患者发生IBD,1.3%IBD患者发生乳糜泻。

核心结论

  • 乳糜泻诊断与IBD之间存在双向关联,在初始评估和随访中需予以关注。
  • 两者共病独立于时间顺序,提示可能存在共同病因。

研究设计与样本

  • 基于瑞典组织病理学和医疗登记数据的全国性登记队列研究。
  • 纳入1969-2016年诊断的48,551例乳糜泻患者和83,529例IBD患者。
  • 每例患者与年龄性别匹配的一般人群对照比较(乳糜泻组对照n=240,136;IBD组对照n=408,195)。
  • 采用Cox回归估计风险比(HR),主要分析限于随访第一年之后的事件以减少监测偏倚。

主要发现

  • 随访期间,784例(1.6%)乳糜泻患者诊断为IBD,对照为1,015例(0.4%)。
  • 乳糜泻患者发生IBD的HR为3.91(95%CI 3.56-4.31),克罗恩病HR为4.36(95%CI 3.72-5.11),溃疡性结肠炎HR为3.40(95%CI 3.00-3.85)。
  • 随访期间,644例(0.8%)IBD患者诊断为乳糜泻,对照为597例(0.1%)。
  • IBD患者发生乳糜泻的HR为5.49(95%CI 4.90-6.16),溃疡性结肠炎HR为6.99(95%CI 6.07-8.05),克罗恩病HR为3.31(95%CI 2.69-4.06)。
  • 乳糜泻与IBD共病时诊断间隔通常<1年,但随访10年后仍可见HR为3-4。

关键数值与推荐

  • 乳糜泻患者发生IBD的HR为3.91(95%CI 3.56-4.31)。
  • IBD患者发生乳糜泻的HR为5.49(95%CI 4.90-6.16)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: To determine the risk of inflammatory bowel disease (IBD) in patients with celiac disease (CeD) (and vice versa ) compared with general-population comparators. METHODS: Using Swedish histopathology and healthcare register data, we identified 48,551 patients with CeD and 83,529 with IBD diagnosed in 1969-2016. Each patient was compared with age- and sex-matched general-population comparators (CeD: n = 240,136; IBD: n = 408,195). Cox regression estimated hazard ratios (HRs) for IBD in patients with CeD and vice versa . Our main analyses were limited to events beyond the first year of follow-up to reduce potential surveillance bias. RESULTS: During follow-up, 784 (1.6%) patients with CeD were diagnosed with IBD compared with 1,015 (0.4%) matched comparators. In patients with CeD, the HR for IBD was 3.91 (95% confidence interval [CI] 3.56-4.31), with largely similar HRs for Crohn's disease (4.36; 3.72-5.11) and ulcerative colitis (3.40; 3.00-3.85). During follow-up, 644 (0.8%) patients with IBD and 597 (0.1%) comparators were diagnosed with CeD. The HR for CeD in patients with IBD was 5.49 (95% CI 4.90-6.16), with the highest risk estimates seen in ulcerative colitis (HR = 6.99; 6.07-8.05), and the HR for Crohn's disease was 3.31 (2.69-4.06). In patients with CeD and IBD, the diagnostic interval was usually <1 year; however, HRs of 3-4 were seen even after 10 years of follow-up. During 20 years of follow-up, 2.5% of patients with CeD developed incident IBD, and 1.3% of patients with IBD developed CeD. DISCUSSION: The bidirectional association between CeD diagnosis and IBD warrants attention in the initial assessment and follow-up of these conditions. Their co-occurrence, independent of temporal sequence, suggests shared etiology.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Mårild K, Söderling J, Lebwohl B, et al. Association of Celiac Disease and Inflammatory Bowel Disease: A Nationwide Register-Based Cohort Study. Am J Gastroenterol. 2022. PMID: 35613563. doi:10.14309/ajg.0000000000001834

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。